Clinical Trial Update: Ph IIA Study (SOC +/- NS5B) [Phase 2]

View source ↗

Summary

Phase IIa study evaluating SOC with or without an NS5B inhibitor for hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED